Igor Vujic

Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression

Martina Sanlorenzo, Igor Vujic, Adil Daud et al. · JAMA Dermatology · 2015 · 445 citations · Full text

Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)

Luca Borradori, Nina van Beek, Claudio Feliciani et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 225 citations · Full text

DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics

Alfonso Latorre, Christian Posch, Yolanda Garcimartín et al. · Nanoscale · 2014 · 77 citations

Nanoparticles, Nanotherapeutics, Engineering +16

Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma

Martina Sanlorenzo, Aditi Choudhry, Igor Vujic et al. · Journal of the American Academy of Dermatology · 2014 · 76 citations · Full text

Skin Cancer, Comparative Profile, Medicine +6

The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients

Christian Posch, Babak Itzinger-Monshi, Tamara Quint et al. · Journal of the American Academy of Dermatology · 2017 · 69 citations

Wide Local Excision, Severe Hidradenitis Suppurativa, Retrospective Analysis +5